FOLR2 and diabetes mellitus: The findings of this study suggest that the functional components in FRB act as anti-inflammatory agents, which may ultimately result in a protective effect with regard to muscle atrophy in diabetic complications, thereby indicating the potential therapeutic applications of FRB in aging and diabetes.